Filing Details

Accession Number:
0001567619-21-004088
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-16 17:00:36
Reporting Period:
2021-02-12
Accepted Time:
2021-02-16 17:00:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442078 V. Sophie Vandebroek One Idexx Drive
Wesbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-12 3,046 $160.28 6,367 No 4 M Direct
Common Stock Disposition 2021-02-12 3,046 $538.20 3,321 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2021-02-12 3,046 $0.00 3,046 $160.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-05-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,000 Indirect by Sophie Vandebroek Revocable Trust
Footnotes
  1. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable on May 3, 2018.
  2. Not applicable.